Mark Rogers Email

Chief Quality and Regulatory Officer . Surgenex

Current Roles

Employees:
84
Revenue:
$13M
About
SURGENEX® is the producer and distributor of the highest quality amniotic membrane tissue allografts in the industry. Human Amniotic Tissue (hAM) is used in a wide variety of clinical settings including: Orthopaedics Sports Medicine Podiatry Pain Management Joint Care SURGENEX® has developed innovative processes and safety protocols, which deliver the highest quality and safety standards. With these safety and quality standards, SURGENEX® is the leader of amniotic membrane tissue allografts in the field of regenerative medicine. The SURGENEX® proprietary Excellion® process is used to produce SurForce®. This patented process is a highly manual and surgical harvesting procedure which generates the highest yield of amniotic tissues. Our placenta recovery processes start where life begins. Qualified mothers donate their placenta for medical treatments and research. These donors are selected through a strict screening process which includes an extensive patient questionnaire, serological testing, and a medical staff interview to ensure donor eligibility. The Excellion® process honors these donations by meticulously collecting the amniotic membrane and carefully removing unwanted tissues such as the chorion. This highly technical process produces the highest quality and the best amniotic tissue allograft in the industry. Learn more at surgenex.com and surgenexcatalog.com!
Surgenex Address
15444 N 76th St
Scottsdale, AZ
Surgenex Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.